Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Mutational Burden in Acute Myeloid Leukemia Is Largely Age Dependent

Aaron C. Shaver, MD PhD, Adam C. Seegmiller, MD PhD, Stephen A. Strickland, MD, Robert D. Daber, PhD, Sanjay R. Mohan, MD, Paul Brent Ferrell, Jr., MD, Cindy Vnencak-Jones, PhD, David R. Head, MD, Annette S. Kim, MD PhD, Mary M. Zutter, MD, Michael R. Savona, MD

Blood (2015) 126 (23): 2605.

https://doi.org/10.1182/blood.V126.23.2605.2605

Published: 2015

Journal Articles

Improvement in Treatment Outcome and Identification of a New Prognostic Parameter in Down Syndrome Acute Myeloid Leukemia (DS-AML): Results of the Children’s Oncology Group (COG) Phase III AAML0431 Trial

Jeffrey W Taub, MD, Jason N Berman, MD, Johann K. Hitzler, MD, April D. Sorrell, MD, Norman J. Lacayo, MD, Kelley Mast, MD, David R. Head, MD, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Robert B. Gerbing, MA, Todd A. Alonzo, PhD, Dario Campana, MD PhD, Elaine Coustan-Smith, MS, Prasad Mathew, Alan S. Gamis, MD MPH

Blood (2014) 124 (21): 278.

https://doi.org/10.1182/blood.V124.21.278.278

Published: 2014

Journal Articles

A High Prevalence of Obesity in Acute Promyelocytic Leukemia (APL): Is Obesity a Risk Factor for APL? Implication of Targeted Therapy to Control Obesity and APL Prevention.

Julianne Qualtieri, MD, Jason Tedesco, MD, Bipin N. Savani, MD, Gregory Ayers, Meera Kumar, John P. Greer, MD, David R. Head, MD, Nishitha Reddy, MD

Blood (2009) 114 (22): 3099.

https://doi.org/10.1182/blood.V114.22.3099.3099

Published: 2009

Journal Articles

Age and acute myeloid leukemia

Frederick R. Appelbaum, Holly Gundacker, David R. Head, Marilyn L. Slovak, Cheryl L. Willman, John E. Godwin, Jeanne E. Anderson, Stephen H. Petersdorf

Blood (2006) 107 (9): 3481–3485.

https://doi.org/10.1182/blood-2005-09-3724

Published: 2006

Journal Articles

Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421

David Becton, Gary V. Dahl, Yaddanapudi Ravindranath, Myron N. Chang, Fred G. Behm, Susana C. Raimondi, David R. Head, Kimo C. Stine, Norman J. Lacayo, Branimir Ivan Sikic, Robert J. Arceci, Howard Weinstein

Blood (2006) 107 (4): 1315–1324.

https://doi.org/10.1182/blood-2004-08-3218

Published: 2006

Journal Articles

Dysregulated Expression of Myeloid Nuclear Differentiation Antigen (MNDA) in MDS: Possible Role in TRAIL-Induced Apoptosis.

Robert C. Briggs, PhD, Keith Shults, BS, Leanne Flye, BS, Sara A. McClintock-Treep, MD, Madan H. Jagasia, MD, Stacey A. Goodman, MD, Fouad I. Boulos, MD, James W. Jacobberger, PhD, Greg Stelzer, PhD, David R. Head, MD

Blood (2005) 106 (11): 4933.

https://doi.org/10.1182/blood.V106.11.4933.4933

Published: 2005

Journal Articles

Myeloid Nuclear Differentiation Antigen (MNDA) Protein Expression in Myelodysplastic Syndrome (MDS) Is Reduced in Maturing Myeloid Cells.

Keith Shults, B.S., David R. Head, M.D., Leanne Flye, B.S., Madan H. Jagasia, M.D., Stacey A. Goodman, M.D., Sara A. McClintock-Treep, M.D., Fouad I. Boulos, M.D., James W. Jacobberger, Ph.D., Greg Stelzer, Ph.D., Robert C. Briggs, Ph.D.

Blood (2004) 104 (11): 4734.

https://doi.org/10.1182/blood.V104.11.4734.4734

Published: 2004

Journal Articles

Hematopoietic Progenitors in Myelodysplastic Syndrome (MDS) Demonstrate Cell Cycle Arrest, Mitotic Failure, and DNA Damage.

David R. Head, M.D., James W. Jacobberger, Ph.D., Madan H. Jagasia, M.D., Stacey A. Goodman, M.D., Leanne Flye, B.S., Sara A. McClintock-Treep, M.D., Fouad I. Boulos, M.D., Fen Jiang, M.D., Greg Stelzer, Ph.D., Robert C. Briggs, Ph.D., Keith Shults, B.S.

Blood (2004) 104 (11): 2375.

https://doi.org/10.1182/blood.V104.11.2375.2375

Published: 2004

Journal Articles

Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase

Alan F. List, Kenneth J. Kopecky, Cheryl L. Willman, David R. Head, Marilyn L. Slovak, Dan Douer, Shaker R. Dakhil, Frederick R. Appelbaum

Blood (2002) 100 (5): 1910–1912.

https://doi.org/10.1182/blood.V100.5.1910.h81702001910_1910_1912

Published: 2002

Journal Articles

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

Alan F. List, Kenneth J. Kopecky, Cheryl L. Willman, David R. Head, Diane L. Persons, Marilyn L. Slovak, Robert Dorr, Chatchada Karanes, Harry E. Hynes, James H. Doroshow, Muhammad Shurafa, Frederick R. Appelbaum

Blood (2001) 98 (12): 3212–3220.

https://doi.org/10.1182/blood.V98.12.3212

Published: 2001

Journal Articles

Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience

Uma H. Athale, Bassem I. Razzouk, Susana C. Raimondi, Xin Tong, Frederick G. Behm, David R. Head, Deo K. Srivastava, Jeffrey E. Rubnitz, Laura Bowman, Ching-Hon Pui, Raul C. Ribeiro

Blood (2001) 97 (12): 3727–3732.

https://doi.org/10.1182/blood.V97.12.3727

Published: 2001

Journal Articles

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

Marilyn L. Slovak, Kenneth J. Kopecky, Peter A. Cassileth, David H. Harrington, Karl S. Theil, Anwar Mohamed, Elizabeth Paietta, Cheryl L. Willman, David R. Head, Jacob M. Rowe, Stephen J. Forman, Frederick R. Appelbaum

Blood (2000) 96 (13): 4075–4083.

https://doi.org/10.1182/blood.V96.13.4075

Published: 2000

Journal Articles

Frequency and Clinical Significance of the Expression of the Multidrug Resistance Proteins MDR1/P-Glycoprotein, MRP1, and LRP in Acute Myeloid Leukemia. A Southwest Oncology Group Study

Catherine P. Leith, Kenneth J. Kopecky, I-Ming Chen, Lisette Eijdems, Marilyn L. Slovak, Thomas S. McConnell, David R. Head, James Weick, Michael R. Grever, Frederick R. Appelbaum, Cheryl L. Willman

Blood (1999) 94 (3): 1086–1099.

https://doi.org/10.1182/blood.V94.3.1086.415k32_1086_1099

Published: 1999

Journal Articles

Early Intensification of Intrathecal Chemotherapy Virtually Eliminates Central Nervous System Relapse in Children With Acute Lymphoblastic Leukemia

Ching-Hon Pui, Hazem H. Mahmoud, Gaston K. Rivera, Michael L. Hancock, John T. Sandlund, Frederick G. Behm, David R. Head, Mary V. Relling, Raul C. Ribeiro, Jeffrey E. Rubnitz, Larry E. Kun, William E. Evans

Blood (1998) 92 (2): 411–415.

https://doi.org/10.1182/blood.V92.2.411

Published: 1998

Journal Articles

A Double-Blind Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor in Elderly Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study (9031)

John E. Godwin, Kenneth J. Kopecky, David R. Head, Cheryl L. Willman, Catherine P. Leith, Harry E. Hynes, Stanley P. Balcerzak, Frederick R. Appelbaum

Blood (1998) 91 (10): 3607–3615.

https://doi.org/10.1182/blood.V91.10.3607

Published: 1998

Journal Articles

Characterization and Use of an Antibody Detecting the CBFβ-SMMHC Fusion Protein in inv(16)/t(16;16)-Associated Acute Myeloid Leukemias

David S. Viswanatha, I.-Ming Chen, Pu Paul Liu, Marilyn L. Slovak, Cathy Rankin, David R. Head, Cheryl L. Willman

Blood (1998) 91 (6): 1882–1890.

https://doi.org/10.1182/blood.V91.6.1882

Published: 1998

Journal Articles

Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study

Catherine P. Leith, Kenneth J. Kopecky, John Godwin, Thomas McConnell, Marilyn L. Slovak, I-Ming Chen, David R. Head, Frederick R. Appelbaum, Cheryl L. Willman

Blood (1997) 89 (9): 3323–3329.

https://doi.org/10.1182/blood.V89.9.3323

Published: 1997

NARROW

Mutational Burden in Acute Myeloid Leukemia Is Largely Age Dependent

Improvement in Treatment Outcome and Identification of a New Prognostic Parameter in Down Syndrome Acute Myeloid Leukemia (DS-AML): Results of the Children’s Oncology Group (COG) Phase III AAML0431 Trial

A High Prevalence of Obesity in Acute Promyelocytic Leukemia (APL): Is Obesity a Risk Factor for APL? Implication of Targeted Therapy to Control Obesity and APL Prevention.

Age and acute myeloid leukemia

Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421

Dysregulated Expression of Myeloid Nuclear Differentiation Antigen (MNDA) in MDS: Possible Role in TRAIL-Induced Apoptosis.

Myeloid Nuclear Differentiation Antigen (MNDA) Protein Expression in Myelodysplastic Syndrome (MDS) Is Reduced in Maturing Myeloid Cells.

Hematopoietic Progenitors in Myelodysplastic Syndrome (MDS) Demonstrate Cell Cycle Arrest, Mitotic Failure, and DNA Damage.

Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

Frequency and Clinical Significance of the Expression of the Multidrug Resistance Proteins MDR1/P-Glycoprotein, MRP1, and LRP in Acute Myeloid Leukemia. A Southwest Oncology Group Study

Early Intensification of Intrathecal Chemotherapy Virtually Eliminates Central Nervous System Relapse in Children With Acute Lymphoblastic Leukemia

A Double-Blind Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor in Elderly Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study (9031)

Characterization and Use of an Antibody Detecting the CBFβ-SMMHC Fusion Protein in inv(16)/t(16;16)-Associated Acute Myeloid Leukemias

Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only